Latest Schedule 13G passive stakes

Stonepine Capital Management has filed a Schedule 13G reporting a 9.99% beneficial ownership stake in Quoin Pharmaceuticals, Ltd.

Manulife Financial Corporation and its subsidiaries have filed a Schedule 13G, reporting a 5.17% beneficial ownership stake in Riverview Bancorp, Inc.

Manulife Financial Corporation and its subsidiaries have filed a Schedule 13G, reporting a 5.17% beneficial ownership stake in Riverview Bancorp, Inc.

Extract Advisors LLC and Darin Milmeister have reported a 7.6% beneficial ownership stake in NexMetals Mining Corp. via a Schedule 13G filing.

Davidson Kempner Capital Management and its affiliates have reported a 0% beneficial ownership stake in Momentus Inc. as of May 8, 2026.

Manulife Financial Corporation and its subsidiaries have reported a combined beneficial ownership of 4.22% in Mobileye Global Inc. Class A Common Stock.

Manulife Financial Corporation and its subsidiaries have reported a combined beneficial ownership of 4.22% in Mobileye Global Inc. Class A Common Stock.

K2 HealthVentures Equity Trust reports a 3.1% beneficial ownership stake in Neumora Therapeutics via debt conversion rights.

Manulife Financial Corporation and its subsidiaries have disclosed a combined 4.98% beneficial ownership stake in Landmark Bancorp, Inc.

Manulife Financial Corporation and its subsidiaries have disclosed a combined 4.98% beneficial ownership stake in Landmark Bancorp, Inc.

Stonepine Capital Management has filed a Schedule 13G reporting a 0.3% beneficial ownership stake in Edesa Biotech, Inc.

Extract Advisors LLC and associated entities have filed a Schedule 13G reporting a 5.4% beneficial ownership stake in NexMetals Mining Corp.

Winklevoss Capital Fund and associated entities have reported a 7.9% beneficial ownership stake in Empery Digital Inc.

Manulife Financial Corporation and its subsidiaries have filed a Schedule 13G reporting a combined 5.45% beneficial ownership stake in First Watch Restaurant Group, Inc.

Manulife Financial Corporation and its subsidiaries have filed a Schedule 13G reporting a combined 5.45% beneficial ownership stake in First Watch Restaurant Group, Inc.

MAK Capital Fund LP and associated entities have filed an amended Schedule 13G reporting a 6.3% beneficial ownership stake in ClearPoint Neuro, Inc.

Ensorcia Metals Corp. and Triomphe Partners LLC have filed a Schedule 13G disclosing a combined beneficial ownership of 5.4% in International Battery Metals Ltd.

Founders Jabbok and William J. Schlacks IV have filed a Schedule 13G disclosing their collective 81% voting power in EquipmentShare.com Inc.

QVT Financial LP has filed a Schedule 13G reporting a 5.71% beneficial ownership stake in Comtech Telecommunications Corp.

Stonepine Capital Management has filed a Schedule 13G reporting a 9.9% beneficial ownership stake in CNS Pharmaceuticals, Inc. consisting of common stock and warrants.

Warren E. Buffett and Berkshire Hathaway Inc. have filed an amendment to their Schedule 13G, reporting a 0% beneficial ownership stake in Liberty Latin America Ltd.

Warren E. Buffett and Berkshire Hathaway Inc. have filed an amendment to their Schedule 13G, reporting a 0% beneficial ownership stake in Liberty Latin America Ltd.

Manulife Financial Corporation and its subsidiaries have filed an amendment to their Schedule 13G, reporting a combined beneficial ownership of 5.0% in Eagle Bancorp Montana, Inc.

Manulife Financial Corporation and its subsidiaries have filed an amendment to their Schedule 13G, reporting a combined beneficial ownership of 5.0% in Eagle Bancorp Montana, Inc.

Vestal Point Capital, LP and Ryan Wilder have filed a Schedule 13G reporting a 6.3% beneficial ownership stake in Taysha Gene Therapies, Inc.

Seven Fleet Master Fund and associated entities have filed a Schedule 13G reporting a 0.5% beneficial ownership stake in CytomX Therapeutics, Inc.

Khrom Capital Management and Eric Khrom have filed a Schedule 13G reporting a 5.66% beneficial ownership stake in Acadia Healthcare Company, Inc.

Maple Rock Capital Partners and Xavier Majic have filed a Schedule 13G reporting a 15.1% beneficial ownership stake in Algoma Steel Group Inc.

Vestal Point Capital, LP and Ryan Wilder have disclosed a beneficial ownership of 8.3% in Bicara Therapeutics Inc., holding 5,425,000 shares of common stock.

Vestal Point Capital, LP and Ryan Wilder have disclosed a passive 5.4% beneficial ownership stake in Enliven Therapeutics, Inc.